These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9275032)

  • 1. Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma.
    Mimori K; Mori M; Shiraishi T; Fujie T; Baba K; Haraguchi M; Abe R; Ueo H; Akiyoshi T
    Br J Cancer; 1997; 76(4):531-6. PubMed ID: 9275032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.
    Shim KN; Jung SA; Joo YH; Yoo K
    J Gastroenterol; 2007 Feb; 42(2):120-8. PubMed ID: 17351800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
    Zhang S; Li L; Lin JY; Lin H
    World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
    Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
    Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
    Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma.
    Mori M; Mimori K; Sadanaga N; Inoue H; Tanaka Y; Mafune K; Ueo H; Barnard GF
    Int J Cancer; 2000 Nov; 88(4):575-8. PubMed ID: 11058873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
    Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma.
    Inoue H; Mimori K; Shiraishi T; Kataoka A; Sadanaga N; Ueo H; Barnard GF; Mori M
    Oncol Rep; 2000; 7(4):871-4. PubMed ID: 10854560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.
    Nuovo GJ; MacConnell PB; Simsir A; Valea F; French DL
    Cancer Res; 1995 Jan; 55(2):267-75. PubMed ID: 7812956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
    Zeng ZS; Guillem JG
    Br J Cancer; 1995 Sep; 72(3):575-82. PubMed ID: 7669564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
    Onisto M; Garbisa S; Caenazzo C; Freda MP; Di Francesco C; Nitti D; Liotta LA; Stetler-Stevenson WG
    Diagn Mol Pathol; 1993 Jun; 2(2):74-80. PubMed ID: 8269280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of malignant transformation of hydatidiform mole by mRNA determination of matrix metalloproteinases and tissue inhibitor of metalloproteinases].
    Li Z; Xiang Y; Dai L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Sep; 35(9):547-50. PubMed ID: 11775947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
    Li L; Zhang S; Lin H; Lin JY
    Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines].
    Lu YG; Ding LC; Zhou HY; Deng SS; Wang QM; Xiong RH; Yang HJ
    Shanghai Kou Qiang Yi Xue; 2006 Oct; 15(5):526-30. PubMed ID: 17348230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
    Zhang M; Teng XD; Guo XX; Li ZG; Han JG; Yao L
    Breast; 2013 Jun; 22(3):330-4. PubMed ID: 22995648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.